Sign in

Lost your password?
(close)
written on 10.11.2020

Resources > White Papers > Reimagining Global Health through Artificial Intelligence: The Roadmap to AI Maturity


main_img

A major new report led by the Novartis Foundation and Microsoft shows how investment in data and AI is critical to drive the health system improvements needed to respond to and recover from the COVID-19 pandemic and the world’s other greatest healthcare challenges.

Reimagining Global Health through Artificial Intelligence: The Roadmap to AI Maturity was developed by the Broadband Commission Working Group on Digital and AI in Health, which the Novartis Foundation and Microsoft co-chair. Based on a landscape review of over 300 existing use cases of AI in health, the report shows how AI is already disrupting health and care. It then presents a roadmap to help countries use AI to transform their health systems from being reactive to proactive, predictive, and even preventive.

Low- and middle-income countries (LMIC) that grapple with systemic health challenges such as a shortage of health workers, underserved populations, rapid urbanization and disinformation have the most to gain from AI – but they also have the most to lose. The response to the COVID-19 pandemic is only an example demonstrating how global health is now data-dependent. However, most countries still need to build these data or make available datasets interoperable, and governments who do not invest risk to further widen health inequities in their populations.


Related White Papers

Intelligent Biopharma: Forging the links across the value chain
Ten Years On: Measuring the Return from Pharmaceutical Innovation 2019
Failure to Launch: Patent Abuse Blocks Access to Biosimilars for America’s Patients
We use cookies to ensure that we give you the best experience on our site. For more info click here